CSURE.TA Gross Margin

The Gross Margin of Cannassure Therapeutics Ltd (CSURE.TA) is 972.00%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

CSURE.TA Gross Margin - Historical Value

Date	Value
2022-12-31	972.00%
2021-12-31	-20.30%
2020-12-31	-412.84%

CSURE.TA Gross Margin - Peers Comparison

Ticker	Name	Value
AVE.AX	Avecho Biotechnology Ltd	59.32%
MRHL.TA	Merchavia Holdings and Investments Ltd	68.42%
TEVA.TA	Teva Pharmaceutical Industries Ltd	50.12%
531398.BO	Source Natural Foods and Herbal Supplements Ltd	38.55%
CGB.AX	Cann Global Ltd	-13.90%
ECS.AX	ECS Botanics Holdings Ltd	36.32%
NYR.AX	Nyrada Inc	-348.25%
REKA.TA	Rekah Pharmaceutical Industry Ltd	22.36%
SEMG.TA	Seach Medical Group Ltd	30.96%
AC8.AX	Auscann Group Holdings Ltd	100.00%
WFL.AX	Wellfully Ltd	53.07%
500422.BO	Transchem Ltd	2.44%
531541.BO	KOBO Biotech Ltd	40.10%
MYDS.TA	Mydas Real Estate Investments Ltd	81.78%
PAA.AX	Neurizon Therapeutics Ltd	79.81%
PNAX.TA	Panaxia Labs Israel Ltd	-52.86%
RNO.AX	Rhinomed Ltd	74.82%
TKUN.TA	Tikun Olam Cannbit Pharmaceuticals Ltd	-3.48%
IXC.AX	Invex Therapeutics Ltd	7775.20%
KREBSBIO.NS	Krebs Biochemicals and Industries Ltd	43.28%
LODZ.TA	Lodzia Real Estate Ltd	73.58%
VISN.TA	Vision Sigma Ltd	40.27%
NXGN.TA	Nextgen Biomed Ltd	36.77%
BKZ.SI	Suntar Eco-City Ltd	6.60%
EMITF.TA	Elbit Imaging Ltd	16.96%